GT Biopharma: quarterly report for the quarter ended Mar 31, 2020

Form: 10-Q
Filed: May 15, 2020, 4:41 pm ET
Period: Mar 31, 2020
Importance: Notable
Accession: 0001654954-20-005654
Document: 10-Q
Exhibit 10.1: Securities purchase agreement by and among the company and the buyers, dated…
Exhibit 10.2: Form of registration rights agreement by and among the company and the buyers…
Exhibit 10.3: Form of note, dated January 30, 2020.
Exhibit 10.4: Securities purchase agreement by and among the company and the buyers, dated…
Exhibit 10.5: Form of registration rights agreement by and among the company and the buyers…
Exhibit 10.6: Form of note, dated april/may, 2020.
Exhibit 10.7: Clinical trial agreement with university of minnesota

Not explained yet; the original is on EDGAR.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.